Creating a framework to speed up the development of vaccines and therapeutics for emerging diseases
Official title: Regulatory Science Core
Funded at University of California-Irvine · NIH-10863339 · Data updated 2026-11-12
This study is working on a way to make it quicker and easier to turn new medical discoveries into safe vaccines and treatments, so patients can get access to them faster, especially for diseases that might come up in the future.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California-Irvine NIH-funded |
| Lab location | 1 site (Irvine, United States) |
| Project start | August 20, 2024 |
| Project end | July 31, 2027 |
| Funding year | 2024 |
| Award (this year) | $1,633,070 |
| NIH project number | 1U19AI181968-01 |
| Project ID | NIH-10863339 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit include individuals at risk for emerging infectious diseases or those involved in clinical trials for new vaccines.
✕Less likely to help
Patients with established diseases that are not related to emerging infectious diseases may not receive direct benefits from this research.
What this research studies
This research focuses on establishing a regulatory framework that facilitates the rapid translation of biomedical discoveries into viable vaccines and therapeutics. By integrating various research efforts, the project aims to streamline the process from initial discovery to clinical testing, ensuring that new vaccine candidates are developed efficiently and meet regulatory standards. Patients may benefit from faster access to new vaccines and treatments for diseases, particularly those that could emerge in the future.
Why it matters
Potential benefit: If successful, this research could lead to quicker development and availability of vaccines and therapeutics for emerging infectious diseases.
How similar studies have gone: Other research initiatives have shown success in developing regulatory frameworks that expedite vaccine development, indicating that this approach is promising.
Where this research is happening
-
University of California-Irvine
Irvine, United States Active
Researchers
- Principal investigator: Bottazzi, Maria Elena — University of California-Irvine
- Study coordinator: Bottazzi, Maria Elena
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.